@misc{oai:repo.qst.go.jp:00071060,
 author = {Shimokawa, Takashi and Nakamura, Etsuko and Sato, Katsutoshi and Iizuka, Daisuke and Kanai, Akinori and Irie, Daisuke and Nakawatari, Miyako and Imai, Takashi and 下川 卓志 and 中村 悦子 and 佐藤 克俊 and 飯塚 大輔 and 入江 大介 and 中渡 美也子 and 今井 高志},
 month = {Feb},
 note = {Radiation therapy has played an important role for treatment of patients diagnosed with cancer. Metastasis, radioresistance and adverse reactions are the most crucial issues for radiotherapy to overcome.  Identification of molecular markers that predict prognosis and/or risk for normal tissues within the irradiated field may help to improve currently available therapies as well as to develop novel therapies.
\nWe have identified several molecular markers for predicting prognosis by using clinical materials, such as biopsies, from patients before/after radiotherapy, including carbon ion radiotherapy. However, it is not possible to obtain biopsies from inaccessible tumors such as those that are targets for carbon ion radiotherapy. To resolve these issues, we have taken blood samples in addition to clinical samples before/after radiation to find novel molecular markers.
\nIn this symposium, I would like to present our research project to identify molecular markers for carbon ion radiotherapy by using the next-generation sequencer at Research Institute for Radiation Biology and Medicine, Hiroshima University., 3rd International symposium　Biological Effects of Low Dose Radiation},
 title = {Next-Generation Sequencing for Identification of Molecular markers in Prognosis of Carbon ion therapy.},
 year = {2013}
}